Table 1 Participants’ demographics and clinical characteristics, stratified by remission status.

SSRI (vs. Placebo)

16 (67)

6 (38)

0.11

Sex: F (vs. M)

17

(71)

11

(69)

1.00

Age (years)

30.24

(14.20)

24.30

(10.80)

32.18

(17.44)

22.95

(24.65)

−0.39

(0.70)

0.11

(0.91)

Week0-HDRS

19.33

(4.94)

18.00

(5.00)

15.56

(3.85)

15.50

(4.50)

2.57

(0.01*)

2.30

(0.02*)

Week1-HDRS

15.92

(3.88)

15.50

(5.50)

13.50

(3.74)

14

(5)

1.96

(0.06)

1.79

(0.07)

Week8-HDRS

14.42

(5.18)

14.00

(6.50)

4.53

(2.19)

4.50

(3.50)

7.19

(<0.01*)

5.32

(<0.01*)

ΔHDRS1

−0.20

(0.20)

−0.19

(0.28)

−0.15

(0.29)

−0.22

(0.27)

−0.61

(0.54)

−0.07

(0.94)

ΔHDRS8

−0.32

(0.30)

−0.24

(0.41)

−1.39

(0.75)

−1.13

(0.48)

6.30

(<0.01*)

5.03

(<0.01*)